These observations suggest a negative inotropic role for cardiac anxA6, and are consistent with transgenic studies in which cardiomyocyte-specific over-expression of anxA6 led to a reduction in the amplitude of Ca2+ transients, impaired contractility and cardiomyopathy [8]. Here, ANXA6 is linked to cardiomyopathy.